North Star Investment Management Decreased By $1.89 Million Its Union Pac Com (UNP) Position; Glaukos (GKOS) Covered By 7 Bulls

Among 7 analysts covering Glaukos Corporation (NYSE:GKOS), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Glaukos Corporation had 32 analyst reports since August 13, 2015 according to SRatingsIntel. The stock has “Outperform” rating by BMO Capital Markets on Wednesday, November 8. The firm has “Buy” rating given on Tuesday, November 7 by Cantor Fitzgerald. On Friday, April 8 the stock rating was initiated by Stifel Nicolaus with “Hold”. Piper Jaffray initiated the shares of GKOS in report on Tuesday, February 9 with “Overweight” rating. Piper Jaffray maintained the stock with “Buy” rating in Wednesday, January 10 report. The firm has “Buy” rating by Roth Capital given on Thursday, April 14. The stock has “Buy” rating by Cantor Fitzgerald on Friday, June 3. On Thursday, August 3 the stock rating was maintained by Roth Capital with “Buy”. The firm has “Buy” rating by Cantor Fitzgerald given on Wednesday, January 10. The company was maintained on Thursday, November 16 by BMO Capital Markets. See Glaukos Corporation (NYSE:GKOS) latest ratings:

10/01/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $48.0 Maintain
10/01/2018 Broker: Piper Jaffray Rating: Buy New Target: $35.0 Maintain
27/12/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $48.0 Maintain
12/12/2017 Broker: Wells Fargo Rating: Buy New Target: $42.0 Maintain
16/11/2017 Broker: BMO Capital Markets Rating: Outperform Old Target: $40 New Target: $38 Maintain
07/11/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $60.0 Maintain
08/11/2017 Broker: BMO Capital Markets Rating: Outperform Old Target: $45 New Target: $40 Maintain
24/10/2017 Broker: Piper Jaffray Rating: Buy New Target: $38.0 Maintain
14/09/2017 Broker: BMO Capital Markets Rating: Buy New Target: $45.0 Maintain
15/09/2017 Broker: Wells Fargo Rating: Buy New Target: $42.0

North Star Investment Management Corp decreased Union Pac Corp Com (UNP) stake by 19.22% reported in 2017Q3 SEC filing. North Star Investment Management Corp sold 16,448 shares as Union Pac Corp Com (UNP)’s stock declined 2.52%. The North Star Investment Management Corp holds 69,142 shares with $8.02 million value, down from 85,590 last quarter. Union Pac Corp Com now has $111.27B valuation. The stock decreased 0.43% or $0.61 during the last trading session, reaching $141.36. About 6.18 million shares traded or 42.74% up from the average. Union Pacific Corporation (NYSE:UNP) has risen 31.45% since January 24, 2017 and is uptrending. It has outperformed by 14.75% the S&P500.

Investors sentiment decreased to 0.9 in 2017 Q3. Its down 0.02, from 0.92 in 2017Q2. It dived, as 67 investors sold UNP shares while 490 reduced holdings. 95 funds opened positions while 408 raised stakes. 601.66 million shares or 1.15% less from 608.67 million shares in 2017Q2 were reported. Horan Cap Management has invested 2.53% in Union Pacific Corporation (NYSE:UNP). Pinebridge Invests Ltd Partnership accumulated 0.12% or 44,634 shares. Rathbone Brothers Public Ltd Co accumulated 38,885 shares or 0.2% of the stock. Barrett Asset Management Ltd invested in 0.05% or 5,795 shares. Perkins Coie Co reported 0.96% stake. Lourd Cap Lc holds 0.02% of its portfolio in Union Pacific Corporation (NYSE:UNP) for 1,789 shares. Burns J W & Inc New York reported 0.24% in Union Pacific Corporation (NYSE:UNP). Commercial Bank stated it has 35,247 shares or 0.45% of all its holdings. Golub Grp Limited Liability Com reported 0.06% in Union Pacific Corporation (NYSE:UNP). Lehman Financial Res has 1,960 shares. Meiji Yasuda Life Ins Communication invested 0.63% in Union Pacific Corporation (NYSE:UNP). Massachusetts Finance Svcs Ma stated it has 0.73% in Union Pacific Corporation (NYSE:UNP). First Heartland Consultants Inc owns 0.15% invested in Union Pacific Corporation (NYSE:UNP) for 5,219 shares. Walleye Trading Ltd Llc has 0% invested in Union Pacific Corporation (NYSE:UNP). Harris Assoc LP holds 0.03% or 163,805 shares.

North Star Investment Management Corp increased Amc Entmt Hldgs Inc Cl A Com (NYSE:AMC) stake by 36,203 shares to 77,703 valued at $1.14 million in 2017Q3. It also upped Freeport (NYSE:FCX) stake by 55,000 shares and now owns 88,728 shares. Texas Instrs Inc Com (NASDAQ:TXN) was raised too.

Among 29 analysts covering Union Pacific Corporation (NYSE:UNP), 13 have Buy rating, 2 Sell and 14 Hold. Therefore 45% are positive. Union Pacific Corporation has $167.0 highest and $78 lowest target. $122.17’s average target is -13.58% below currents $141.36 stock price. Union Pacific Corporation had 95 analyst reports since July 24, 2015 according to SRatingsIntel. Bank of America upgraded the shares of UNP in report on Monday, February 22 to “Buy” rating. UBS upgraded the shares of UNP in report on Tuesday, January 9 to “Buy” rating. The firm has “Outperform” rating given on Friday, January 22 by RBC Capital Markets. The firm earned “Neutral” rating on Friday, December 4 by Bank of America. The rating was downgraded by Aegis Capital to “Hold” on Tuesday, October 10. Cowen & Co maintained it with “Hold” rating and $116.0 target in Thursday, September 28 report. The stock of Union Pacific Corporation (NYSE:UNP) has “Buy” rating given on Friday, October 2 by Citigroup. The stock has “Hold” rating by Stifel Nicolaus on Monday, September 18. The rating was maintained by TD Securities with “Buy” on Friday, October 27. On Monday, October 12 the stock rating was maintained by Deutsche Bank with “Buy”.

Glaukos Corporation, an ophthalmic medical technology company, focuses on the development and commercialization of products and procedures designed to treat glaucoma. The company has market cap of $1.03 billion. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. It currently has negative earnings. The companyÂ’s product pipeline includes iStent Inject trabecular micro-bypass stent that allows the surgeon to inject stents into various trabecular meshwork locations through a single corneal entry with the goal of achieving intraocular pressure reduction; iStent Supra suprachoroidal micro-bypass stent, which is designed to reduce intraocular pressure by accessing the suprachoroidal space in the eye; and iDose, a targeted injectable drug delivery implant that is designed to be pre-loaded into a small gauge needle and injected into the eye through a self-sealing corneal needle penetration.

The stock increased 2.28% or $0.66 during the last trading session, reaching $29.66. About 553,634 shares traded. Glaukos Corporation (NYSE:GKOS) has risen 54.04% since January 24, 2017 and is uptrending. It has outperformed by 37.34% the S&P500.